Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics (GALT), said “In the U.S. approximately 5 million adults are ...

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended ...

Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated fatty liver disease (MAFLD) occurs when excess fat builds up in the liver. MAFLD can progress to metabolic ...

Learn about the increased pressure in the portal vein, its causes like cirrhosis, and resulting complications such as ...

SimplyMiles doesn’t fit into any other category. It’s not quite a shopping portal and it’s not a bank-issued program. And that makes it a perfect pairing for stacking offers. To get started ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

Researchers provide a conceptual overview of liver vasomics, including the classification of vascular phenotypes in the liver ...

Hypertension leads to the thickening and narrowing of small blood vessels in the kidneys, reducing blood flow and function. This causes salt and water accumulation, further increasing blood ...

Underlying such questions is a subtle cynicism that the reversibility of fibrosis and cirrhosis has been overhyped—yet another example of the medical media 'spin machine' giving false hope to ...

However, a higher systolic blood pressure threshold of 160 mm Hg is provided for individuals aged 80 years and older and for younger individuals with both grade 1 hypertension and a low risk of ...

In a later report Sposito and Cheli 5 described 10 patients with liver disease and parotid enlargement, 6 of whom had portal cirrhosis although only 1 was alcoholic. The remainder, 1 patient each ...